Articles From: Ferrellgas Partners Reports Record Fiscal 2014 Results: Gross Profit, Adjusted EBITDA and Distributable Cash Flow to FICO Joins The CardLinx Association


OVERLAND PARK, Kan., Dec.
Sign-up for Ferrellgas Partners Reports Strong First Quarter; Reaffirms Fiscal 2015 Earnings Guidance investment picks
OVERLAND PARK, Kan., Nov.
Sign-up for Ferrellgas Partners, L.P. Declares First Quarter Cash Distribution investment picks
OVERLAND PARK, Kan., Sept.
Sign-up for Ferrellgas to Expand Eagle Ford Midstream Operations; Announces Acquisition of Two Additional Facilities investment picks
2014/12/2
Ferro Corporation (NYSE: FOE, “Company”) announced today that it has completed the acquisition of tile coating manufacturer Vetriceramici S.p.A. for €83 million (approximately $104 million), subject to customary working capital and other purchase price adjustments.
Sign-up for Ferro Completes Acquisition of Italian Tile Coatings Manufacturer Vetriceramici investment picks
2014/9/21
Ferro Corporation (NYSE: FOE, “Company”) announced today that it has signed a definitive agreement with Milan, Italy-based Private Equity Funds’ Management Company Star Capital SGR S.p.A. and two minority owners and founders Gianfranco Padovani and Sergio Zannoni to acquire Casola Valsenio, Italy-based Vetriceramici S.p.A. for €83 million (approximately $108 million) in cash.
Sign-up for Ferro Enters into Agreement to Acquire Italian Tile Coatings Manufacturer Vetriceramici investment picks
2014/10/27
Ferro Corporation (NYSE: FOE, the “Company”) today reported results for the third quarter ended September 30, 2014.
Sign-up for Ferro Reports 33% Increase in Third Quarter Adjusted EPS from Continuing Operations investment picks
Ferro Corporation (NYSE: FOE) announced today that it will conduct a conference call on Tuesday, October 28, 2014 at 10:00 a.m. Eastern Time to discuss financial results for the three months ended September 30, 2014, and provide a current view of 2014 business conditions.
Sign-up for Ferro Schedules Conference Call for 2014 Third-Quarter Results investment picks
2014/11/27
SANTA ISN'T THE ONLY ONE putting on a suit.
Sign-up for Festive Fashion for Christmas investment picks
2014/12/8
Consumers Energy Shows Energy Value, Shares Fire Marshal Safety Tips JACKSON, Mich.
Sign-up for Festive Holiday Indoor, Outdoor Lighting Less Than $4 Month investment picks
2014/9/16
RE/MAX National Housing Report on 52 Metro Areas DENVER , Sept.
Sign-up for Fewer Home Sales, Slower Price Increases investment picks
2014/11/13
AUBURN HILLS, Mich.
Sign-up for FIAT Brand North America and Vans Expand Partnership investment picks
2014/12/11
By WSJ Staff Fiat Chrysler Automobiles NV said it priced an offering of 87 million common shares at $11 apiece.
Sign-up for Fiat Chrysler Prices Offering at $11 a Share -- Update investment picks
http://media.marketwire.com/attachments/200903/512688_IKA_Logo_3C_RGB.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1151595&ProfileId=051205&sourceType=1 FREMONT, CA --
Sign-up for FiberHome Selects Ikanos Velocity-3 Chipset to Deliver High-Speed Broadband Solutions to Carriers in Multiple Geographies, Including China investment picks
FibraHotel (BMV:FIHO 12), the first real estate investment trust specialized in urban business-class hotels in Mexico, and Starwood Hotels & Resorts Worldwide, Inc. (NYSE:HOT), today announced the sale of the Sheraton® Ambassador Monterrey hotel to FibraHotel, adding 229 rooms to FibraHotel’s portfolio.
Sign-up for FibraHotel Acquires the Sheraton Ambassador Hotel in Monterrey, Mexico from Starwood Hotels & Resorts investment picks
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company primarily focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases, and Intrexon Corporation (NYSE:XON), a leader in synthetic biology, today announced plans to file an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) in the first half of 2015 for their drug candidate, GM-HDF-COL7 (genetically-modified human dermal fibroblast, collagen VII). The companies are developing this new cell-based therapeutic for the treatment of recessive dystrophic epidermolysis bullosa (RDEB), the most severe form of the rare connective tissue disorder epidermolysis bullosa.
Sign-up for Fibrocell Science and Intrexon Advance GM-HDF-COL7 toward Clinical Development for the Treatment of Recessive Dystrophic Epidermolysis Bullosa investment picks
EXTON, Pa., Oct.
Sign-up for Fibrocell Science Announces Chief Financial Officer Transition investment picks
EXTON, Pa., Oct.
Sign-up for Fibrocell Science Honored With 2014 Marcum Innovator of the Year Award investment picks
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that John Maslowski, vice president, scientific affairs of Fibrocell Science will present on Tuesday, October 7 at 2:30 p.m. PDT at the 4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa to be held October 7-9 in La Jolla, California.
Sign-up for Fibrocell Science to Present at 2014 Stem Cell Meeting on the Mesa investment picks
Fibrocell Science, Inc., (NASDAQ:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that David Pernock, chairman and chief executive officer of Fibrocell Science will present at the BioCentury NewsMakers in the Biotech Industry conference at 9:30 a.m. EDT on Friday, September 26, 2014, in New York City.
Sign-up for Fibrocell Science to Present at BioCentury NewsMakers of the Biotech Industry Conference investment picks
FibroGen, Inc. (NASDAQ:FGEN), a research-based biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics to treat serious unmet medical needs, today announced that the underwriters of its initial public offering exercised in full their option to purchase an additional 1,215,000 shares of common stock from FibroGen at the initial public offering price of $18.00 per share, less the underwriting discount.
Sign-up for FibroGen, Inc. Announces Full Exercise of Greenshoe Option investment picks
Revenue of $222 million vs.
Sign-up for FICO Announces Earnings of $1.10 per Share for Fourth Quarter Fiscal 2014 investment picks
SAN JOSE, Calif.
Sign-up for FICO Declares Quarterly Cash Dividend investment picks
FICO invites early adopter partners and developers to join the new program to create, market and sell their wares in the FICO Analytic Cloud and marketplace SAN DIEGO , Nov.
Sign-up for FICO Introduces New FICO Analytic Cloud Partner Network investment picks
Predictive analytic and decision management technologies key for card-linked offers industry SAN JOSE, Calif.
Sign-up for FICO Joins The CardLinx Association investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Ferrellgas Partners Reports Record Fiscal 2014 Results: Gross Profit, Adjusted EBITDA and Distributable Cash Flow to FICO Joins The CardLinx Association
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent